A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developments
作者： María Teresa Bobes-Bascarán , María Paz García-Portilla , Pilar A. Sáiz Martínez , Leticia García-Alvarez , Isabel Menéndez-Miranda
DOI: 10.1007/978-3-319-30061-0_5
关键词: Patient management 、 Perspective (graphical) 、 Schizophrenia (object-oriented programming) 、 Differential item functioning 、 Outcome (game theory) 、 Life satisfaction 、 Psychology 、 Clinical trial 、 Quality of life (healthcare) 、 Psychiatry
摘要: The assessment of quality life (QoL) in patients with schizophrenia is an area growing concern since it considered essential distal outcome for clinical trials and patient management (Auquier et al. 2003; Awad Voruganti 2012) according to the patient-reported (PRO) movement medicine (see Fig. 5.1). Its evaluation founded on notion that every has a right self-determination health-care decisions his/her subjective perspective should be both diagnosis care planning processes (Awad 2012; Badia 1999; Bilker 2003).
springer.com
core.ac.uk
sci-hub.st 参考文章(48)
Julio Bobes, Maria Paz Garcia-Portilla, Maria Teresa Bascaran, Pilar Alejandra Saiz, Manuel Bouzoño, None, Quality of life in schizophrenic patients. Dialogues in clinical neuroscience. ,vol. 9, pp. 215- 226 ,(2007)
Jean Endicott, Wilma Harrison, John Nee, Richard Blumenthal, Quality of Life Enjoyment and Satisfaction Questionnaire: A New Measure. Psychopharmacology Bulletin. ,vol. 29, pp. 321- 326 ,(1993)
Quality of life as patient-reported outcomes: principles of assessment. Dialogues in clinical neuroscience. ,vol. 16, pp. 137- 145 ,(2014) , 10.31887/DCNS.2014.16.2/MBULLINGER
The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues in clinical neuroscience. ,vol. 16, pp. 185- 195 ,(2014) , 10.31887/DCNS.2014.16.2/AKAROW
Luis Gaite, José Luis Vázquez-Barquero, Andrés Arriaga Arrizabalaga, Aart H. Schene, Birgitte Welcher, Graham Thornicroft, Mirella Ruggeri, Elena Vázquez-Bourgon, Modesto Pérez Retuerto, Morven Leese, , Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile – European Version: EPSILON Study 8 British Journal of Psychiatry. ,vol. 177, pp. 49- 54 ,(2000) , 10.1192/BJP.177.39.S49
Jeffrey A. Lieberman, Diana Perkins, Aysenil Belger, Miranda Chakos, Fred Jarskog, Kalina Boteva, John Gilmore, The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches Biological Psychiatry. ,vol. 50, pp. 884- 897 ,(2001) , 10.1016/S0006-3223(01)01303-8
D Naber, A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology. ,vol. 10, pp. 133- 138 ,(1995) , 10.1097/00004850-199509000-00017
Greg Wilkinson, Bernadette Hesdon, Diane Wild, Ron Cookson, Carole Farina, Vimal Sharma, Ray Fitzpatrick, Crispin Jenkinson, Self-report quality of life measure for people with schizophrenia: the SQLS. British Journal of Psychiatry. ,vol. 177, pp. 42- 46 ,(2000) , 10.1192/BJP.177.1.42
Michael Ritsner, Rena Kurs, Anatoly Gibel, Yael Ratner, Jean Endicott, Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Quality of Life Research. ,vol. 14, pp. 1693- 1703 ,(2005) , 10.1007/S11136-005-2816-9
Juan Carlos Gomez, Jose Antonio Sacristan, Jesus Hernandez, Alan Breier, Patricio Ruiz Carrasco, César Antón Saiz, Eva Fontova Carbonell, None, The Safety of Olanzapine Compared With Other Antipsychotic Drugs: Results of an Observational Prospective Study in Patients With Schizophrenia (EFESO Study) The Journal of Clinical Psychiatry. ,vol. 61, pp. 335- 343 ,(2000) , 10.4088/JCP.V61N0503